GBS Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GBS research report →
Companygbs.inc
GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva.
- CEO
- Harry Simeonidis
- IPO
- 2020
- Employees
- 12
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $433.58K
- P/E
- -0.39
- P/S
- 0.47
- P/B
- 0.50
- EV/EBITDA
- 0.30
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 32.08%
- Op Margin
- -300.26%
- Net Margin
- -296.76%
- ROE
- -174.16%
- ROIC
- -110.43%
Growth & Income
- Revenue
- $3.05M · -1.90%
- Net Income
- $-10,568,733 · -4.06%
- EPS
- $-2.00 · 67.21%
- Op Income
- $-10,644,607
- FCF YoY
- -3.47%
Performance & Tape
- 52W High
- $2.89
- 52W Low
- $0.36
- 50D MA
- $0.47
- 200D MA
- $0.65
- Beta
- 0.00
- Avg Volume
- 51.58K
Get TickerSpark's AI analysis on GBS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 4, 23 | Sakiris Spiro Kevin | other | 0 |
| Oct 4, 23 | TOWERS CHRISTOPHER | buy | 9,090 |
| Oct 4, 23 | TOWERS CHRISTOPHER | buy | 9,090 |
| Oct 4, 23 | TOWERS CHRISTOPHER | buy | 9,090 |
| Oct 4, 23 | Sakiris Spiro Kevin | buy | 112,727 |
| Oct 4, 23 | Sakiris Spiro Kevin | buy | 112,727 |
| Oct 4, 23 | Sakiris Spiro Kevin | buy | 112,727 |
| Sep 1, 23 | Simeonidis Harry | buy | 50 |
| Aug 31, 23 | Simeonidis Harry | buy | 100 |
| May 10, 23 | Sakiris Spiro Kevin | other | 2,399 |
Our GBS Coverage
We haven't published any research on GBS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GBS Report →